ZFIN ID: ZDB-FISH-150901-3952
Fish name: mi4Tg
Genotype: mi4Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by mi4Tg
No data available
GENE EXPRESSION
Gene expression in mi4Tg
RNA expression
Expressed Gene Structure Conditions Figures
alcama physical alteration: anatomical structure Fig. 6 from Fausett et al., 2006
ascl1a standard conditions Fig. 4 from Fausett et al., 2008
chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
physical alteration: eye Fig. 4Fig. 8 from Mitra et al., 2019
Fig. 1Fig. 2 from Ramachandran et al., 2012
Fig. 1 with imageFig. 4 with image from Ramachandran et al., 2011
Fig. 4 from Fausett et al., 2008
dkk1a physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
dkk1b physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
dkk2 physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
dkk3a physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
dkk3b physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
fzd2 chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
physical alteration: anatomical structure Fig. 1 with imageFig. 2 with imageFig. 4 with image from Ramachandran et al., 2011
fzd3a physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
fzd8a physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
fzd8b physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
fzd9a physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
gapdh physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
gli3 perforation: retina Fig. 1 with image from Kaur et al., 2018
hdac1 perforation: retina Fig. 6 from Mitra et al., 2019
her4.1 perforation: retina, chemical treatment: 10058-F4 Fig. 7Fig. 8 from Mitra et al., 2019
igf1ra perforation: retina Fig. 2 with image from Wan et al., 2014
igf1rb perforation: retina Fig. 2 with image from Wan et al., 2014
igfbp3 perforation: retina Fig. 2 with image from Wan et al., 2014
insm1a mechanical stress Fig. 5 from Mitra et al., 2019
Fig. 1Fig. 2 from Ramachandran et al., 2012
insra perforation: retina Fig. 1 with image from Wan et al., 2014
insrb perforation: retina Fig. 1 with image from Wan et al., 2014
lin28ab chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
physical alteration: anatomical structure Fig. 6Fig. 8 from Mitra et al., 2019
Fig. 4 with image from Ramachandran et al., 2011
Fig. 1 from Ramachandran et al., 2010
max perforation: retina Fig. 2 from Mitra et al., 2019
myca chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
physical alteration: anatomical structure Fig. 1Fig. 2Fig. 4Fig. 8 from Mitra et al., 2019
Fig. 4 with image from Ramachandran et al., 2011
mycb perforation: retina, chemical treatment: 10058-F4 Fig. 1Fig. 2Fig. 4Fig. 6Fig. 8 from Mitra et al., 2019
pax6a standard conditions Fig. 7 from Fausett et al., 2008
Fig. 4 from Fausett et al., 2006
chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
physical alteration: anatomical structure Fig. 4 with image from Ramachandran et al., 2011
Fig. 4 from Fausett et al., 2006
ptch1 perforation: retina Fig. 1 with image from Kaur et al., 2018
shha perforation: retina Fig. 1 with image from Kaur et al., 2018
smo perforation: retina Fig. 1 with image from Kaur et al., 2018
tuba1b physical alteration: eye Fig. 7 from Fausett et al., 2008
wnt2 physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
wnt2ba physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
wnt3 physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
wnt4 chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
physical alteration: anatomical structure Fig. 1 with imageFig. 2 with imageFig. 4 with image from Ramachandran et al., 2011
wnt8b physical alteration: anatomical structure Fig. 1 with imageFig. 2 with image from Ramachandran et al., 2011
PHENOTYPE
Phenotype in mi4Tg
Phenotype Conditions Figures
fin regeneration decreased efficacy, abnormal amputation: caudal fin, chemical treatment: 10058-F4 Fig. 3 from Mitra et al., 2019
Muller cell cell dedifferentiation decreased occurrence, abnormal perforation: retina, chemical treatment: Cyclopamine Fig. 1 with image from Kaur et al., 2018
Muller cell cell population proliferation decreased occurrence, abnormal perforation: retina, chemical treatment: 10058-F4 Fig. 3 from Mitra et al., 2019
Muller cell cell population proliferation decreased occurrence, abnormal perforation: retina, chemical treatment: DAPT Fig. 8 from Mitra et al., 2019
Muller cell cell population proliferation decreased occurrence, abnormal perforation: retina, chemical treatment by injection: sirolimus Fig. 3 from Zhang et al., 2019
Muller cell cell population proliferation increased occurrence, abnormal perforation: retina, chemical treatment: DAPT Fig. 8 from Mitra et al., 2019
regenerating tissue cell population proliferation decreased occurrence, abnormal perforation: retina, chemical treatment: 10058-F4 Fig. 3 from Mitra et al., 2019
regenerating tissue cell population proliferation decreased occurrence, abnormal perforation: retina, chemical treatment by injection: sirolimus Fig. 3 from Zhang et al., 2019
regenerating tissue Muller cell decreased amount, abnormal perforation: retina, chemical treatment by environment: dexamethasone Fig. 8 from Zhang et al., 2019
regenerating tissue Muller cell decreased amount, abnormal perforation: retina, chemical treatment: Cyclopamine Fig. 1 with image from Kaur et al., 2018
regenerating tissue Muller cell decreased amount, abnormal perforation: retina, chemical treatment by injection: sirolimus Fig. 3 from Zhang et al., 2019
regenerating tissue Muller cell increased amount, abnormal perforation: retina, chemical treatment by injection: (1->3)-beta-D-glucan Fig. 8 from Zhang et al., 2019
regenerating tissue retina ascl1a expression decreased amount, abnormal perforation: retina, chemical treatment: 10058-F4 Fig. 4 from Mitra et al., 2019
regenerating tissue retina her4.1 expression decreased amount, abnormal perforation: retina, chemical treatment: DAPT Fig. 8 from Mitra et al., 2019
regenerating tissue retina mycb expression decreased amount, abnormal perforation: retina, chemical treatment: 10058-F4 Fig. 4 from Mitra et al., 2019
regenerating tissue retina insm1a expression decreased amount, abnormal perforation: retina, chemical treatment: 10058-F4 Fig. 5 from Mitra et al., 2019
regenerating tissue retina lin28ab expression increased amount, abnormal perforation: retina, chemical treatment: DAPT Fig. 8 from Mitra et al., 2019
regenerating tissue retina mycb expression increased amount, abnormal perforation: retina, chemical treatment: DAPT Fig. 8 from Mitra et al., 2019
regenerating tissue retina lin28ab expression increased amount, abnormal perforation: retina, chemical treatment: 10058-F4 Fig. 6 from Mitra et al., 2019
regenerating tissue retina her4.1 expression increased amount, abnormal perforation: retina, chemical treatment: 10058-F4 Fig. 7 from Mitra et al., 2019
regenerating tissue retina myca expression increased amount, abnormal perforation: retina, chemical treatment: DAPT Fig. 8 from Mitra et al., 2019
regenerating tissue retina ascl1a expression increased amount, abnormal perforation: retina, chemical treatment: DAPT Fig. 8 from Mitra et al., 2019
retina regeneration process quality, abnormal physical alteration: anatomical structure, chemical treatment: pharmaceutical Fig. 2 with image from Powell et al., 2013

CITATIONS  (19)